SL
BIIB icon

Savior LLC’s Biogen BIIB Stock Holding History

Savior LLC’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-20
Closed -$5K – 179
2022
Q3 		$5K Hold
20
– – ﹤0.01% 144
2022
Q2 		$4K Buy
+20
New +$4.09K ﹤0.01% 133
2021
Q3 		– Sell
-34
Closed -$12K – 246
2021
Q2 		$12K Hold
34
– – 0.01% 368
2021
Q1 		$10K Hold
34
– – 0.01% 398
2020
Q4 		$8K Hold
34
– – 0.01% 448
2020
Q3 		$10K Buy
34
+10
+42% +$2.79K 0.01% 369
2020
Q2 		$6K Hold
24
– – 0.01% 421
2020
Q1 		$8K Hold
24
– – 0.01% 352
2019
Q4 		$7K Buy
+24
New +$6.66K 0.01% 489

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Savior LLC's BIIB Position: Q4 2022 in Review

Savior LLC sold out of Biogen (BIIB) in Q4 2022, closing a stake of 20 shares — an estimated $5K sold.

Savior LLC first reported a position in BIIB in Q4 2019 and held it in 9 quarters. The position peaked at $12K in Q2 2021. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

  • Savior LLC reported no remaining Biogen position as of Q4 2022 after selling out during the quarter.
  • Savior LLC sold 20 Biogen shares in Q4 2022, an estimated $5K.
  • Savior LLC first reported a position in Biogen in Q4 2019 and held it in 9 quarters.
  • Savior LLC's Biogen position peaked at $12K in Q2 2021.
  • 1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on Savior LLC's 13F filing for Q4 2022, filed 13 Jan 2023.